Total Payments
$934.00
2022 Payments
$19.89
Companies
11
Transactions
59
Medicare Patients
774
Medicare Billing
$123,996
Payment Breakdown by Category
Food & Beverage$934.00 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $934.00 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $181.69 | 10 | $0 (2018) |
| Allergan Inc. | $164.10 | 12 | $0 (2018) |
| ViiV Healthcare Company | $147.06 | 9 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $142.89 | 10 | $0 (2019) |
| AbbVie, Inc. | $86.64 | 6 | $0 (2018) |
| Melinta Therapeutics, Inc. | $50.96 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $45.99 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $45.98 | 3 | $0 (2018) |
| Theratechnologies Inc. | $34.31 | 2 | $0 (2018) |
| SANOFI PASTEUR INC. | $19.89 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $19.89 | 1 | SANOFI PASTEUR INC. ($19.89) |
| 2020 | $53.81 | 3 | ViiV Healthcare Company ($39.32) |
| 2019 | $48.94 | 3 | Merck Sharp & Dohme Corporation ($29.88) |
| 2018 | $447.46 | 29 | Allergan Inc. ($116.57) |
| 2017 | $363.90 | 23 | Gilead Sciences Inc ($107.78) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2022 | SANOFI PASTEUR INC. | QUADRACEL (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Vaccines | ||||||
| 02/26/2020 | Oxford Immunotec USA Inc | TSPOT TB TEST (Device) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diagnostic Test | ||||||
| 02/20/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: HIV | ||||||
| 01/21/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: HIV | ||||||
| 10/23/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), RENFLEXIS | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/11/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: VACCINE | ||||||
| 04/18/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ANTIBIOTICS | ||||||
| 12/13/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: HIV | ||||||
| 12/06/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/01/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/04/2018 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/20/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: HIV | ||||||
| 09/06/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/30/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Virology | ||||||
| 08/23/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 08/21/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/09/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.55 | General |
| 08/07/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/26/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/05/2018 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/21/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 05/31/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: HIV | ||||||
| 05/22/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 118 | 258 | $91,114 | $24,525 |
| 2022 | 5 | 210 | 405 | $132,786 | $36,463 |
| 2021 | 6 | 206 | 391 | $95,720 | $28,512 |
| 2020 | 7 | 240 | 504 | $103,705 | $34,497 |
Total Patients
774
Total Services
1,558
Medicare Billing
$123,996
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 127 | $46,436 | $12,290 | 26.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 86 | $27,683 | $7,744 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 45 | $16,995 | $4,491 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 203 | $73,979 | $20,343 | 27.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 57 | $21,638 | $5,983 | 27.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 62 | $17,856 | $4,911 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 50 | $10,000 | $2,666 | 26.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 33 | 33 | $9,313 | $2,561 | 27.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 175 | $34,650 | $9,930 | 28.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 73 | 75 | $21,000 | $5,928 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 46 | $13,662 | $4,708 | 34.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 62 | $12,710 | $4,201 | 33.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $7,650 | $2,003 | 26.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $6,048 | $1,741 | 28.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 81 | 257 | $47,463 | $14,959 | 31.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 76 | $17,178 | $6,414 | 37.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 36 | 36 | $15,012 | $5,849 | 39.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 69 | $12,946 | $3,975 | 30.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 37 | 38 | $10,616 | $3,152 | 29.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 12 | 14 | $308.00 | $106.54 | 34.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 12 | 14 | $182.00 | $41.16 | 22.6% |
About Dr. Elizabeth Lien, M.D
Dr. Elizabeth Lien, M.D is a Infectious Disease healthcare provider based in Tacoma, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851489827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Lien, M.D has received a total of $934.00 in payments from pharmaceutical and medical device companies, with $19.89 received in 2022. These payments were reported across 59 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($934.00).
As a Medicare-enrolled provider, Lien has provided services to 774 Medicare beneficiaries, totaling 1,558 services with total Medicare billing of $123,996. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Tacoma, WA
- Active Since 10/11/2006
- Last Updated 08/01/2012
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1851489827
Products in Payments
- AVYCAZ (Drug) $136.61
- Mavyret (Drug) $86.64
- TRIUMEQ (Drug) $70.23
- ISENTRESS (Drug) $69.26
- PREZCOBIX (Drug) $45.99
- DOVATO (Drug) $39.32
- Baxdela (Drug) $39.21
- JULUCA (Drug) $37.51
- Cresemba (Drug) $28.87
- QUADRACEL (Biological) $19.89
- EGRIFTA (Drug) $19.68
- ZEPATIER (Drug) $17.81
- ZERBAXA (Drug) $17.36
- CRESEMBA (Drug) $17.11
- DALVANCE (Drug) $15.95
- TROGARZO (Drug) $14.63
- TSPOT TB TEST (Device) $14.49
- PNEUMOVAX 23 (Biological) $12.52
- NOXAFIL (Drug) $12.33
- Vabomere (Drug) $11.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Tacoma
Lawrence Schwartz, Md, MD
Infectious Disease — Payments: $2,562
Infectious Disease $2,562
Dr. Roumen Iordanov, M.d, M.D
Infectious Disease — Payments: $1,039
Infectious Disease $1,039
Dr. Michael Stein, M.d, M.D
Infectious Disease — Payments: $482.02
Infectious Disease $482.02
David Mceniry, M.d, M.D
Infectious Disease — Payments: $164.10
Infectious Disease $164.10
Ramona Popa, Md, MD
Infectious Disease — Payments: $153.91
Infectious Disease $153.91
Dr. Susan Fraser, Md, MD
Infectious Disease — Payments: $148.16
Infectious Disease $148.16